| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $400,313 ) |
| 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 001 | 5 | 5/26/2025 | NON-COMPETING CONTINUATION | $40,032 |
| 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 000 | 5 | 4/28/2025 | NON-COMPETING CONTINUATION | $360,281 |
|
 | Issue Date FY: 2024 ( Subtotal = $380,298 ) |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 000 | 4 | 6/7/2024 | NON-COMPETING CONTINUATION | $380,298 |
|
 | Issue Date FY: 2023 ( Subtotal = $392,306 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 000 | 3 | 5/22/2023 | NON-COMPETING CONTINUATION | $392,306 |
|
 | Issue Date FY: 2022 ( Subtotal = $392,306 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 000 | 2 | 8/25/2022 | NON-COMPETING CONTINUATION | $392,306 |
|
 | Issue Date FY: 2021 ( Subtotal = $400,313 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cancer Treatment Research | 000 | 1 | 5/19/2021 | NEW | $400,313 |
|
|